Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Martine A. Rothblatt currently holds 8,213 shares of UNITED THERAPEUTICS CORP (UTHR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Martine A. Rothblatt has been a net seller of UTHR stock. They have purchased $0 and sold $549.4M worth of shares.
Martine A. Rothblatt's most recent insider trade was on Jun 11, 2026, when they sold 7,142 shares at $0.00 per share.
Martine A. Rothblatt serves as Executive at UNITED THERAPEUTICS CORP (UTHR). They have executed 2000 insider transactions totaling $549.4M over their tenure at the company.
Martine A. Rothblatt holds the position of Executive at UNITED THERAPEUTICS CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
Martine A. Rothblatt has shown a selling trading pattern, with $0 in total purchases and $549.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Martine A. Rothblatt was on Dec 15, 2025, when they sold $1.7M worth of UTHR shares. This transaction involved 3,500 shares at $495.14 per share.
Martine A. Rothblatt currently owns 8,213 shares of UNITED THERAPEUTICS CORP (UTHR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Martine A. Rothblatt's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Martine A. Rothblatt has 2000 Form 4 filings on record as an insider at UNITED THERAPEUTICS CORP.
Set alerts for Martine A. Rothblatt and 40,000+ other insiders.